NCT06743997View on ClinicalTrials.gov

A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

April 15, 2025

Study Completion Date

April 15, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

Test Drug (Eutropin Catridge, 48IU/Cartridge)

Liqid somatropin

DRUG

Reference Drug (Eutropin, 4 IU/vial)

Lyophilized somatropin

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

LG Chem
All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT06743997 - A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability | Biotech Hunter | Biotech Hunter